NC Medicaid has approved the following codes for COVID-19-related medically necessary laboratory testing and has completed adding these services in NCTracks. Please note there are other codes currently under review that will be posted at a later date.
|
Code |
Description |
Effective Date |
|
U0001 |
2019 Novel Coronavirus Real Time RT-PCR Diagnostic Test Panel – CDC |
Feb. 24, 2020 |
|
U0002 |
2019 Novel Coronavirus Test – Non-CDC |
Feb. 24, 2020 |
|
C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
March 01, 2020 |
|
87635 |
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique |
March 13, 2020 |
|
U0003 |
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique, making use of high throughput technologies. |
March 18, 2020 |
|
U0004 |
2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC, making use of high throughput technologies |
March 18, 2020 |
|
86328 |
Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (e.g., reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID19]) |
April 20, 2020 |
|
86769 |
Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
April 20, 2020 |
|
G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), any specimen source |
March 01, 2020 |
|
G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), from an individual in a SNF or by a laboratory on behalf of a HHA, any specimen source |
March 01, 2020 |
|
87426 |
Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19]). |
Sept. 01, 2020 |
Providers can now be reimbursed for uninsured individuals who enroll in NC Medicaid Optional Testing (MCV). Enrollment information can be found in Medicaid Special Bulletin COVID-19 #128. NC Medicaid Be Smart Family Planning program (MAFDN) beneficiaries are eligible for the MCV testing but do not need to complete this application.
Medical office providers can be reimbursed for COVID-19 specimen collection using CPT code 99211 (ESTABLISHED PATIENT OFFICE OR OTHER OUTPATIENT VISIT, TYPICALLY 5 MINUTES) with modifier CR. CMS has approved the use of this code for new patients when used for specimen collection.
Providers should regularly check the NCDHHS COVID-19 webpage for the most up-to-date information and resources.
CONTACT
NCTracks Contact Center: (800) 688-6696